Author

Diana Moreno

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Brenda MelendeziD· 1 shared Collene R. JeteriD· 1 shared Deena M ScovilleiD· 1 shared Elizabeth M. WhitleyiD· 1 shared Hyun-Eui KimiD· 1 shared Jae‐Wook JeongiD· 1 shared Joseph CelestinoiD· 1 shared Karen Lu· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brenda MelendezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome-associated MSH2-deficient endometrial cancer

Mikayla Borthwick Bowen, Brenda Melendez, Qian Zhang, Diana Moreno, Leah Peralta, WaiKin Chan, Collene R. Jeter, Lin Tan, Malgorzata Anna Zal, Philip L. Lorenzi, Kenneth Dunner, Richard Kenneth Yang, Russell R. Broaddus, Joseph Celestino, Nisha Gokul, , Melinda S. Yates

This study identifies mitochondrial dysfunction and metabolic reprogramming in MSH2-deficient endometrial cancer, revealing a novel pathway and potential therapeutic targets.

JCI Insight · Feb 18, 2025Peer-reviewedCancer Biology